The ScientistAntiviral Immunotherapy Comes of Age | The Scientist Magazine®The ScientistT-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections.What… Continue reading
Subtle cues can dictate the fate of stem cellsPhys.OrgInhibiting only GSK3-beta could also provide a useful tool for producing stem cells that are not merely "pluripotent" but able to contribute to the formation of embryos. These so-called na… Continue reading
UCSF News ServicesNew Immunotherapy for Deadly Childhood Brain Cancer Targets …UCSF News ServicesChildren with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of… Continue reading
Endpoints News |
Mustang Bio Launches CRISPR/Cas9 CAR–T Collaborations with Harvard, BIDMC
Genetic Engineering & Biotechnology News Mustang Bio said today it plans to develop CRISPR/Cas9-enhanced chimeric antigen receptor engineered T–cell (CAR-T) therapies for cancer through a license from Harvard University and a research collaboration agreement with Beth Israel Deaconess Medical … CRISPR/Cas9 pioneer Chad Cowan enlists in Mustang Bio’s CAR-T … Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel … |
Endpoints News |
CRISPR/Cas9 pioneer Chad Cowan enlists in Mustang Bio’s CAR-T …
Endpoints News The tech race spawned by a blockbuster scramble to the top of the emerging CAR-T sector has inspired a tie-up between one of the pioneering scientists involved with CRISPR/Cas9 gene editing and an up-and-comer cancer drug developer that is working on a … Mustang Bio Launches CRISPR/Cas9 CAR-T Collaborations with Harvard, BIDMCGenetic Engineering & Biotechnology News Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel …Nasdaq |